Cyclenium, Ono partner for macrocycles

Cyclenium Pharma Inc. (Sherbrooke, Quebec) partnered with Ono Pharmaceutical Co. Ltd. (Tokyo:4528) to discover and develop therapeutics using next-generation synthetic small molecule macrocycles against undisclosed targets selected by Ono.

Ono will screen Cyclenium's macrocycle QUEST Library and Cyclenium will then use its CMRT technology to generate macrocyclic compounds. Ono will characterize the biological and pharmacological properties and have worldwide rights to develop and commercialize resulting compounds...